Healthy Inc > Blog > Mefenamic Acid manufacturer India
Posted on:

Is mefenamic acid safe for pregnancy?

In the pharmaceutical industry, Mefenamic Acid (an anthranilic acid derivative NSAID) is handled with extreme caution regarding pregnancy. As a pharmacist and manufacturer, I must be direct: Mefenamic Acid is generally not recommended during pregnancy, and it is strictly contraindicated (forbidden) during the third trimester.

At your WHO-GMP facility in Mumbai, where you likely produce this for dysmenorrhea and mild-to-moderate pain, ensuring that your product inserts reflect the latest FDA and WHO “Safety Signals” is critical for regulatory compliance in 2026.

The Pregnancy Safety Matrix

Stage of PregnancySafety StatusTechnical Rationale
First TrimesterAvoidSome studies suggest a slight increase in the risk of miscarriage and congenital heart defects.
Second TrimesterCaution (Use only if essential)Recent FDA warnings (since 2020) state that NSAIDs can cause Oligohydramnios (low amniotic fluid) due to fetal kidney dysfunction.
Third TrimesterStrictly ContraindicatedHigh risk of premature closure of the Ductus Arteriosus (a vital fetal heart shunt) and delayed labor.

Technical Mechanism: The Prostaglandin Blockade

The reason Mefenamic Acid is dangerous in late pregnancy is rooted in its primary mechanism of action:

Enzyme Inhibition: It inhibits COX-1 and COX-2 enzymes, blocking the production of prostaglandins.

Ductus Arteriosus: In the fetus, prostaglandins are required to keep the ductus arteriosus open. When an NSAID blocks these, the ductus can close too early, leading to fetal pulmonary hypertension.

Renal Impact: Prostaglandins also maintain fetal renal blood flow. Blocking them can lead to fetal kidney failure and a subsequent drop in amniotic fluid levels.

The Pharmacist’s “Technical Warning”

  • The 20-Week Rule: Since 2020, regulatory bodies advise avoiding all NSAIDs (including Mefenamic Acid) from 20 weeks of gestation onwards due to the risk of kidney issues in the unborn baby.

  • Safer Alternatives: For fever or pain during pregnancy, Paracetamol remains the gold standard for safety across all trimesters.

  • Fertility Impact: Like other NSAIDs, Mefenamic Acid may delay ovulation. For patients trying to conceive, it should be used sparingly.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Labeling Compliance” USP: On your digital marketplace, highlight that your Summary of Product Characteristics (SmPC) is updated with the latest 2026 pregnancy warnings. This is a major trust factor for international B2B buyers in the EU and North America.

  • Stability for Export: Mefenamic Acid is stable but should be protected from light. Utilizing opaque Alu-Alu blister packaging ensures a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers with comprehensive “Contraindications” sections to support your firm’s registration in international tenders.

Mefenamic Acid Tablets

Posted on:

What is Mefenamic Acid 500mg used for?

In the pharmaceutical industry, Mefenamic Acid 500 mg is a prominent Non-Steroidal Anti-Inflammatory Drug (NSAID) belonging to the fenamate class. As a pharmacist and manufacturer, I view Mefenamic Acid as a specialized analgesic particularly prized for its efficacy in gynecological and dental applications. It is often considered more effective than paracetamol for inflammatory and spasmodic pain.

Primary Clinical Uses

  • Dysmenorrhea (Period Pain): The most common indication. It reduces uterine contractions and the associated pain/cramps.

  • Menorrhagia: Used to reduce excessive menstrual blood loss (when organic pathology is ruled out).

  • Mild to Moderate Acute Pain: Effective for dental pain, post-operative pain, and musculoskeletal injuries.

  • Inflammatory Conditions: Symptomatic relief of Rheumatoid Arthritis (including Still’s Disease) and Osteoarthritis.

  • Headaches & Fever: Used for tension headaches and as an antipyretic to reduce high body temperature.

Mechanism of Action: The “Dual” Inhibitor

What makes Mefenamic Acid unique compared to other NSAIDs is its dual approach to managing pain:

Inhibition of Synthesis: Like most NSAIDs, it inhibits the COX-1 and COX-2 enzymes, preventing the formation of prostaglandins from arachidonic acid.

Receptor Blockade: Uniquely, Mefenamic Acid is also believed to block prostaglandin receptors that have already been formed. This makes it exceptionally effective for uterine pain, where prostaglandin levels are already high.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Mefenamic Acid 500 mg is a high-volume essential product:

  • Bioavailability Challenges: Mefenamic Acid is a BCS Class II drug (low solubility, high permeability). At our WHO-GMP facility, we focus on micronization of the API and the use of specific surfactants to ensure the 500 mg tablet meets the strict dissolution standards of BP/USP/IP.

  • Gastric Protection: Due to its high potential for GI irritation, we often recommend patients take it with food. As a manufacturer, we ensure our Product Information Leaflet (PIL) clearly highlights this.

  • Stability for Export: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Dossier Support: This is a staple for women’s health distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ponstan).

Mefenamic Acid Tablets

Add to cart